Fluconazole (Zonal)

Subscribe to Selected New Research on Fluconazole

3117 relevant articles (495 outcomes, 452 trials/studies) found for this Drug

Description: Triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in AIDS.

Also Known As:

Zonal; AbZ Brand of Fluconazole; Aliud Brand of Fluconazole; Alpharma Brand of Fluconazole; Apo-Fluconazole; Apotex Brand of Fluconazole; Armstrong Brand of Fluconazole; Béagyne; Chemia Brand of Fluconazole; Diflucan; Effik Brand of Fluconazole; Fluc Hexal; FlucoLich; Flucobeta; Fluconazol AL; Fluconazol AbZ; Fluconazol Stada; Fluconazol von ct; Fluconazol-Isis; Fluconazol-ratiopharm; Flunazul; Fungata; Hexal Brand of Fluconazole; Lavisa; Lesvi Brand of Fluconazole; Lichtenstein Brand of Fluconazole; Loitin; Mack Brand of Fluconazole; Neofomiral; Oxifungol; Pfizer Brand of Fluconazole; Pfleger Brand of Fluconazole; SAT Brand of Fluconazole; Silanes Brand of Fluconazole; Solacap; Stada Brand of Fluconazole; Triflucan; UK-49858; Vita Brand of Fluconazole; betapharm Brand of Fluconazole; ct-Arzneimittel Brand of Fluconazole; ratiopharm Brand of Fluconazole; Apo Fluconazole; Fluconazol Isis; Fluconazol ratiopharm; UK 49858; UK49858; ct Arzneimittel Brand of Fluconazole; 1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-difluorophenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-

Relationship Network

Drug Context: Research Results

Heterocyclic Compounds: 23

1-Ring Heterocyclic Compounds

Experts

1.	Walsh, Thomas J: 5 articles (06/2007 - 09/2004)
2.	Patterson, Thomas F: 4 articles (11/2005 - 06/2002)
3.	Yamaguchi, Hideyo: 4 articles (01/2004 - 01/2002)
4.	Uchida, Katsuhisa: 4 articles (01/2004 - 01/2002)
5.	Wheat, L J: 4 articles (02/2003 - 05/2000)
6.	Larsen, Robert A: 3 articles (06/2008 - 07/2003)
7.	Ullmann, Andrew J: 3 articles (01/2007 - 02/2006)
8.	Pappagianis, D: 3 articles (09/2006 - 06/2000)
9.	Sobel, Jack D: 3 articles (11/2005 - 06/2004)
10.	Hooton, Thomas M: 3 articles (12/2004 - 08/2004)

Related Diseases

1.	Infection 01/01/2007 - "Its emergence spectrum varies from mucosal to systemic infections and the first line treatment is still based on fluconazole, a triazole derivate with a potent antifungal activity against most of C" 02/01/2004 - "Prophylaxis by fluconazole has dramatically reduced the frequency of early Candida infections" 05/15/2002 - "Fluconazole prophylaxis is highly effective for the control of invasive yeast infections and associated with few breakthrough infections" 12/06/2001 - "We evaluated the efficacy of prophylactic fluconazole in preventing fungal colonization and invasive infection in extremely-low-birth-weight infants" 06/01/1998 - "Fluconazole is active in vitro against the most common pathogens, penetrates into the nail bed, and is clinically effective in the treatment of a wide variety of fungal infections" Order ALL the reference details at left...
2.	Candidiasis (Moniliasis) 04/01/1990 - "In summary, fluconazole was most effective against disseminated candidiasis in persistently granulocytopenic rabbits when used for prevention or early treatment." 04/01/1990 - "Fluconazole was most effective when used for preventive or early treatment of acute and subacute disseminated candidiasis" 08/01/1991 - "CONCLUSION: Fluconazole is a safe and effective agent with significant activity against chronic disseminated candidiasis." 11/01/1990 - "The convenience, good tolerance and clinical efficacy of fluconazole make it the therapy of choice for oropharyngeal candidiasis in immunologically compromised patients." 01/01/1997 - "The efficacy of fluconazole to prevent systemic candidiasis was recently documented in multicentric studies in bone marrow recipients but is more controversial in neutropenic patients" Order ALL the reference details at left...
3.	Acquired Immunodeficiency Syndrome (AIDS) 07/01/1994 - "High-dose fluconazole appears safe and effective for cryptococcal disease in AIDS patients." 02/01/1996 - "Improved standardization of fluconazole susceptibility testing has resulted in demonstrable correlations between yeast resistance in vitro and in vivo for this agent in the AIDS setting" 06/01/1991 - "Safety and efficacy of fluconazole treatment for Candida oesophagitis in AIDS." 10/01/2002 - "This study provides important baseline data as the isolates were collected prior to fluconazole being made freely available to HIV/AIDS patients attending government health clinics." 05/01/1999 - "Conditional logistic regression was used to study demographic and AIDS-related variables in addition to fluconazole and steroid use" Order ALL the reference details at left...
4.	Cryptococcal Meningitis 03/01/1992 - "Fluconazole is highly effective in suppressing relapses of cryptococcal meningitis" 07/01/1994 - "Eight patients (6, cryptococcal meningitis; 2, high-titer cryptococcal antigenemia) were treated with 800 mg/day fluconazole to assess the safety and efficacy of high-dose fluconazole as primary therapy" 03/01/1992 - "Fluconazole, an orally active antifungal agent, has been shown to be clinically beneficial for maintenance therapy of cryptococcal meningitis" 03/04/1995 - "Although the optimum dose and duration of fluconazole could not be determined, our results suggest that less than daily use was effective in the prevention of cryptococcal meningitis." 05/01/1994 - "CONCLUSION: Fluconazole is an effective treatment for cryptococcal meningitis" Order ALL the reference details at left...
5.	Cryptococcosis 08/01/1986 - "Fluconazole was highly effective in suppressing cryptococcosis in mice challenged by the intravenous and intranasal routes, and was comparable with the other two drugs in its protective capacity" 06/15/2003 - "Fluconazole is useful in the treatment of CNS cryptococcosis, because it attains high concentration in the CNS" 09/01/2006 - "Fluconazole is effective in the treatment of pulmonary cryptococcosis in these patients." 01/01/1995 - "Treatment with fluconazole was effective in 2 months on the cryptococcosis" 01/01/1992 - "In primary treatment of cryptococcosis, fluconazole is well tolerated, but is effective in only 50% of patients" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Amphotericin B (Amphotericin)
2.	Itraconazole (Sporanox)
3.	Ketoconazole (Nizoral)
4.	Flucytosine (Ancobon)
5.	terbinafine (Lamisil)
6.	Clotrimazole (Lotrimin)
7.	Nystatin (Mycostatin)
8.	voriconazole (Vfend)
9.	Griseofulvin (Grifulvin V)
10.	ICI 195739

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Transplantation (Transplant Recipients)
3.	Bone Marrow Transplantation (Transplantation, Bone Marrow)
4.	Transplants (Transplant)
5.	Vitrectomy

Best Treatments:
Research Summary Report
on Infection

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 13871 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>